Related Experiment Video

Updated: May 17, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Pharmacophore-based drug design and biological evaluation of novel ABCB1 inhibitors

Sheng-lie Zhang1, Yin-xiang Wei, Qian Li

  • 1School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

Chemical Biology & Drug Design
|October 26, 2012
PubMed

Insights

Overexpression of the ABCB1 transporter causes multidrug resistance in cancer chemotherapy. This study developed a pharmacophore model to identify novel ABCB1 inhibitors, leading to the discovery of potential lead compounds YZ-3 and YZ-16.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Overexpression of ABCB1 (P-glycoprotein) is a significant obstacle in cancer chemotherapy, contributing to multidrug resistance and limiting oral drug bioavailability.
  • Inhibiting ABCB1 activity is a key strategy to overcome chemoresistance and improve the efficacy of cancer treatments.

Purpose of the Study:

  • To develop a 3D pharmacophore model for ABCB1 inhibitors.
  • To identify novel potent ABCB1 inhibitors through database screening.
  • To validate the inhibitory activity of identified compounds using biological assays.

Main Methods:

  • Construction and validation of a 3D pharmacophore model based on known ABCB1 inhibitors.
  • Virtual screening of an in-house 3D database using the developed pharmacophore model.
  • In vitro evaluation of identified hit compounds using rhodamine 123 accumulation, chemosensitization, and cell permeability assays.

Main Results:

  • A validated 3D pharmacophore model was generated, comprising three hydrophobic features and one hydrogen bond acceptor.
  • Virtual screening identified several potential ABCB1 inhibitors from the in-house database.
  • Compounds YZ-3 and YZ-16 demonstrated significant inhibitory activity in biological assays, showing potential as lead compounds.

Conclusions:

  • The developed 3D pharmacophore model is effective for identifying novel ABCB1 inhibitors.
  • Compounds YZ-3 and YZ-16 represent promising lead candidates for the development of new drugs to combat multidrug resistance in cancer therapy.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...